XM does not provide services to residents of the United States of America.
A
A

AstraZeneca

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study

Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study Oct 17 (Reuters) - Merck MRK.N said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing respiratory syncytial virus (RSV) infections in infants. The seasonal shot met its primary goal in the mid-to-late stage trial, reducing the incidence of lower respiratory tract infections in healthy infants up to one year of age entering their first RSV season.
A
P
S
S

Consumer groups ask FTC to block Novo Holdings-Catalent deal

UPDATE 2-Consumer groups ask FTC to block Novo Holdings-Catalent deal Consumer groups and unions express competition concerns to FTC Deal could limit options for competitors developing GLP-1 drugs Concerns also raised about impact on gene therapy manufacturing Adds comment from Novartis on Zolgensma in last paragraph By Jody Godoy and Maggie Fick NEW YORK, Oct 17 (Reuters) - U.S.
A
A
N
N
P
R

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Consumer groups ask FTC to block Novo Holdings-Catalent deal Consumer groups and unions express competition concerns to FTC Deal could limit options for competitors developing GLP-1 drugs Concerns also raised about impact on gene therapy manufacturing By Jody Godoy, Maggie Fick NEW YORK, Oct 17 (Reuters) - Five U.S. consumer groups and two large labor unions urged the U.S.
A
A
N
N
P
R

US natgas prices ease to 4-week low on mild weather forecasts

UPDATE 2-US natgas prices ease to 4-week low on mild weather forecasts Adds latest prices By Scott DiSavino Oct 17 (Reuters) - U.S. natural gas futures eased 1% to a four-week low on Thursday on forecasts for mild weather over the next two weeks that should keep heating demand lower than normal for this time of year. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 2.0 cents, or 0.8%, to settle at $2.347 per million British thermal units (mmBtu), their
A
N

US natgas prices edge up 1% on higher demand, ahead of storage report

US natgas prices edge up 1% on higher demand, ahead of storage report By Scott DiSavino Oct 17 (Reuters) - U.S. natural gas futures edged up about 1% on Thursday on forecasts for higher demand next week than previously expected. The small price move came ahead of a federal report expected to show that utilities last week added less gas to storage than usual for a 13th week in a row.
A
N

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.